PureBMC

N/A

Report date: 2022/12/17 16:53:18

Base Information

Drug NamePureBMC

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, Hip

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Cleveland Clinic Foundation

China Registration ClassN/A

Develop Information

Active CompaniesThe Cleveland Clinic Foundation

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, Hip

Inactive IndicationsN/A

Other Information

ATC CodeN/A